Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.17 BRL | +8.69% | +4.40% | -4.04% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company shows low valuation levels, with an enterprise value at 0.51 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.04% | 200M | - | ||
+6.15% | 105B | A- | ||
-4.19% | 65.16B | A- | ||
+51.90% | 42.93B | B | ||
+17.59% | 39.48B | B | ||
+7.56% | 33.27B | A- | ||
+12.88% | 19.92B | B- | ||
+16.25% | 17.49B | C+ | ||
+20.35% | 15.43B | B- | ||
+10.05% | 15.09B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DEXP3 Stock
- Ratings Dexxos Participações S.A.